Biobank for the Molecular Classification of Kidney Disease, Canada

Certification Status: Approved
Registration Status: Completed

Objective: The Biobank for the Molecular Classification of Kidney Disease (BMCKD) facilitates the epidemiological, molecular and genetic testing of kidney disease and kidney disease risk factors. This unique facility is interfaced by clinical and research domains in order to provide long-term storage space by partnering with laboratory services, as well as to supply data and biospecimens to clinician scientists studying kidney disease.

Registered Biobank Name Biobank for the Molecular Classification of Kidney Disease
Biobank Leader Michelle Nelson
Country Canada
Email for biobank inquiries
Principal Investigator Dr. Daniel A. Muruve
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: